Cogent Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	723	506	808	342	127	22	132
Market Cap Growth	-	-37.32%	136.30%	168.44%	476.79%	-83.26%	-
Enterprise Value	489	260	567	124	-111	-11	52
PE Ratio	-2.63	-2.63	-5.76	-4.73	-0.71	-0.69	-3.82
PS Ratio	-	-	-	-	16.18	0.98	13.56
PB Ratio	2.86	1.96	3.16	1.60	0.54	0.70	2.19
P/FCF Ratio	-3.24	-3.24	-6.44	-5.65	-3.59	-0.53	-3.99
P/OCF Ratio	-3.30	-3.30	-6.81	-5.82	-3.55	-0.53	-4.06
EV/Sales Ratio	-	-	-	-	-14.08	-0.47	5.35
EV/EBITDA Ratio	-1.37	-1.37	-4.22	-1.77	1.50	0.35	-1.57
EV/EBIT Ratio	-1.35	-1.35	-4.04	-1.72	1.48	0.33	-1.51
EV/FCF Ratio	-1.66	-1.66	-4.52	-2.05	3.12	0.26	-1.58
Debt / Equity Ratio	0.07	0.07	0.08	0.01	0.02	0.19	-
Debt / EBITDA Ratio	-0.10	-0.10	-0.15	-0.04	-0.07	-0.20	-
Debt / FCF Ratio	-0.12	-0.12	-0.16	-0.05	-0.15	-0.15	-
Quick Ratio	6.96	6.96	9.70	12.94	18.59	3.07	3.27
Current Ratio	7.09	7.09	9.87	13.04	18.70	3.06	3.25
Asset Turnover	0	0	0	0	0.07	0.35	0.12
Return on Equity (ROE)	-67.90%	-67.90%	-53.30%	-34.00%	-278.50%	-85.20%	-96.50%
Return on Assets (ROA)	-58.10%	-58.10%	-46.50%	-31.60%	-155.60%	-49.40%	-42.30%
Return on Capital (ROIC)	-75.23%	-75.23%	-53.68%	-34.76%	-34.27%	-85.14%	-59.78%
Earnings Yield	-26.13%	-37.99%	-17.36%	-21.14%	-140.69%	-144.15%	-26.18%
FCF Yield	-21.25%	-30.89%	-15.53%	-17.69%	-27.89%	-187.21%	-25.04%
Buyback Yield / Dilution	-35.61%	-35.61%	-51.66%	-249.52%	-45.42%	-22.43%	-144.27%
Total Shareholder Return	-35.61%	-35.61%	-51.66%	-249.52%	-45.42%	-22.43%	-144.27%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).